The tumor suppressor maspin mediates E2F1-induced sensitivity of cancer cells to chemotherapy
- PMID: 20197383
- DOI: 10.1158/1541-7786.MCR-09-0137
The tumor suppressor maspin mediates E2F1-induced sensitivity of cancer cells to chemotherapy
Abstract
The E2F1 transcription factor is a critical downstream target of the tumor suppressor RB. When activated, E2F1 can induce cell proliferation and/or apoptosis. In addition, E2F1 overexpression sensitizes cancer cells to chemotherapeutic drugs. In a screen for genes that are regulated synergistically by E2F1 and chemotherapy in cancer cells, we identified the proapoptotic tumor suppressor gene maspin (mammary serine protease inhibitor) as a novel E2F1-regulated gene. In line with being an E2F-regulated gene, maspin expression is inhibited by short hairpin RNA directed against E2F1 and increases upon activation of endogenous E2F. Furthermore, maspin mRNA and protein levels are elevated upon activation of exogenous E2F1. Importantly, we show that E2F1-mediated upregulation of maspin is enhanced by chemotherapeutic drugs, and inhibition of maspin expression significantly impairs the ability of E2F1 to promote chemotherapy-induced apoptosis. Summarily, our data indicate that maspin is an important effector of E2F1-induced chemosensitization.
Similar articles
-
Translating DNA damage into cancer cell death-A roadmap for E2F1 apoptotic signalling and opportunities for new drug combinations to overcome chemoresistance.Drug Resist Updat. 2010 Aug-Oct;13(4-5):119-31. doi: 10.1016/j.drup.2010.06.001. Epub 2010 Aug 1. Drug Resist Updat. 2010. PMID: 20675184 Review.
-
MiR-15 and miR-16 are direct transcriptional targets of E2F1 that limit E2F-induced proliferation by targeting cyclin E.Mol Cancer Res. 2011 Apr;9(4):440-7. doi: 10.1158/1541-7786.MCR-10-0344. Epub 2011 Mar 31. Mol Cancer Res. 2011. PMID: 21454377
-
The tumor suppressor gene hypermethylated in cancer 1 is transcriptionally regulated by E2F1.Mol Cancer Res. 2009 Jun;7(6):916-22. doi: 10.1158/1541-7786.MCR-08-0359. Epub 2009 Jun 2. Mol Cancer Res. 2009. PMID: 19491197
-
Focused PCR screen reveals p53 dependence of nitric oxide-induced apoptosis and up-regulation of maspin and plasminogen activator inhibitor-1 in tumor cells.Mol Cancer Res. 2009 Jan;7(1):55-66. doi: 10.1158/1541-7786.MCR-08-0331. Mol Cancer Res. 2009. PMID: 19147537
-
Biological functions of maspin.J Cell Physiol. 2006 Dec;209(3):617-24. doi: 10.1002/jcp.20782. J Cell Physiol. 2006. PMID: 17001697 Review.
Cited by
-
E2F1 Affects the Therapeutic Response to Neoadjuvant Therapy in Breast Cancer.Dis Markers. 2022 Sep 17;2022:8168517. doi: 10.1155/2022/8168517. eCollection 2022. Dis Markers. 2022. Retraction in: Dis Markers. 2023 Jul 26;2023:9870104. doi: 10.1155/2023/9870104. PMID: 36164372 Free PMC article. Retracted.
-
Tumor suppressor maspin as a rheostat in HDAC regulation to achieve the fine-tuning of epithelial homeostasis.Crit Rev Eukaryot Gene Expr. 2012;22(3):249-58. doi: 10.1615/critreveukargeneexpr.v22.i3.80. Crit Rev Eukaryot Gene Expr. 2012. PMID: 23140166 Free PMC article. Review.
-
The long non-coding RNA ERIC is regulated by E2F and modulates the cellular response to DNA damage.Mol Cancer. 2013 Oct 29;12(1):131. doi: 10.1186/1476-4598-12-131. Mol Cancer. 2013. PMID: 24168400 Free PMC article.
-
Maspin reprograms the gene expression profile of prostate carcinoma cells for differentiation.Genes Cancer. 2011 Nov;2(11):1009-22. doi: 10.1177/1947601912440170. Genes Cancer. 2011. PMID: 22737267 Free PMC article.
-
Reactivation of MASPIN in non-small cell lung carcinoma (NSCLC) cells by artificial transcription factors (ATFs).Epigenetics. 2011 Feb;6(2):224-35. doi: 10.4161/epi.6.2.13700. Epub 2011 Feb 1. Epigenetics. 2011. PMID: 20948306 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
